Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1869 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | VEGF | 1827.5 | 66 | |
RA1869 | Poly(I:C) | 2 | ug/mL | 1 | VEGF | 1674.0 | 39 | ||||
N2759 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | VEGF | 1540.0 | 45 | |
N2759 | Poly(I:C) | 2 | ug/mL | 1 | VEGF | 1381.0 | 47 | ||||
RA1931 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | VEGF | 1950.0 | 55 | |
RA1931 | Poly(I:C) | 2 | ug/mL | 1 | VEGF | 2705.5 | 34 | ||||
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | VEGF | 1745.5 | 50 | |
N2586 | Poly(I:C) | 2 | ug/mL | 1 | VEGF | 1820.5 | 28 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 1 | VEGF | 656.0 | 49 | ||||
RA1869 | IKK16 | 2.0 | uM | 1 | VEGF | 1256.0 | 49 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 1 | VEGF | 955.0 | 65 | ||||
N2759 | IKK16 | 2.0 | uM | 1 | VEGF | 785.5 | 38 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 1 | VEGF | 1147.5 | 78 | ||||
RA1931 | IKK16 | 2.0 | uM | 1 | VEGF | 1214.0 | 60 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 1 | VEGF | 972.0 | 59 | ||||
N2586 | IKK16 | 2.0 | uM | 1 | VEGF | 1020.5 | 48 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 1 | VEGF | 1345.5 | 52 | ||||
RA1869 | 1 | VEGF | 1377.5 | 62 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 1 | VEGF | 1288.0 | 50 | ||||
N2759 | 1 | VEGF | 1522.5 | 52 | |||||||
RA1931 | Tofacitinib | 0.3 | uM | 1 | VEGF | 1297.0 | 56 | ||||
RA1931 | 1 | VEGF | 1238.0 | 64 | |||||||
N2586 | Tofacitinib | 0.3 | uM | 1 | VEGF | 1550.0 | 37 | ||||
N2586 | 1 | VEGF | 1264.0 | 52 | |||||||
0 | VEGF | 45.0 | 45 |